Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
The success of screening, an important cancer prevention tool, depends on the quality and efficiency of protocols and guidelines for screening and follow-up. However, even centrally organized screening programs such as the Dutch cervical screening program occasionally show problems in performance. To improve this program, the screening scheme, follow-up, administration and financing protocols and guidelines were thoroughly changed in 1996. This study evaluates the consequences for the performance of the national program. Five-year coverage rate, the proportion of screened women sent to follow-up, follow-up compliance and duration, and the yearly number of Pap smears before and after the changes in 1996 were compared. Five-year coverage increased substantially in the added target age groups (30-34, and 54-60 years); in the old target age group (35-53 years) it remained around 80%. The percentage of screened women sent to follow-up decreased from almost 19-3% per screening round, due to a more restrictive use of the Pap 2 classification, and an evidence-based cessation of follow-up of negative smears without endocervical cells. Follow-up compliance has improved, and the average time until a woman is either referred or rejoins the regular screening schedule, has become shorter. The total number of smears, a strong determinant of screening costs, has decreased by 20% primarily due to the changed follow-up recommendations. In conclusion, the 1996 changes in protocols and guidelines, and their implementation have increased coverage and efficiency, and decreased the screening-induced negative side effects.
Rebolj
Matejka
M
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. m.rebolj@erasmusmc.nl
van Ballegooijen
Marjolein
M
Berkers
Louise-Maria
LM
Habbema
Dik
D
D000328:Adult; D002584:Cervix Uteri / Q000473:pathology*; D003581:Cytodiagnosis; D005260:Female; D005500:Follow-Up Studies; D006284:Health Plan Implementation; D006801:Humans; D008403:Mass Screening; D008875:Middle Aged; D009313:National Health Programs / Q000592:standards*; D009426:Netherlands / Q000453:epidemiology; D065006:Papanicolaou Test; D017410:Practice Guidelines as Topic; D011230:Precancerous Conditions / Q000175:diagnosis*; D015397:Program Evaluation; D012017:Referral and Consultation; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D014626:Vaginal Smears / Q000379:methods